Nuclear and cytoplasmic Maspin expression in primary non‐small cell lung cancer
AUTOR(ES)
Woenckhaus, Matthias
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1994526Documentos Relacionados
- Targeted therapies in non-small cell lung cancer
- Molecular characteristics of non-small cell lung cancer
- Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer
- Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
- Preoperative chemotherapy improves outcomes in non-small cell lung cancer